This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Please provide your email address to receive an email when new articles are posted on . The results of a 3-year trial recently published in The Lancet provide compelling evidence that selective laser ...

Glaucoma is one of the leading causes of permanent blindness in the world, affecting more than two million Americans, and more than one hundred million people worldwide. It is a disease of the optic ...

MOUNTAIN VIEW, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal ...

Please provide your email address to receive an email when new articles are posted on . Laser trabeculoplasty was described in 1979 and involved an argon modality to noninvasively treat the trabecular ...

Iridex Corporation announced the publication of a significant peer-reviewed study in Ophthalmology Therapy, demonstrating the long-term safety and efficacy of MicroPulse Transscleral Laser Therapy ...

Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...

Belkin Laser, a small Israel-based biotechnology company, has announced that it has completed enrollment for its pivotal, Phase III trial investigating a new, laser-based treatment option for patients ...

Experts explain whether Lasik or lens implants affect your risk, and how a hair strand-like microshunt could reduce reliance on lifelong eye drops for patients.

More than 70 million people worldwide suffer from glaucoma. Treatment options have traditionally included eye drops to reduce the fluid the eye produces or surgery to unclog the eye's drainage. But a ...